Dr Megan Levings (General Surgery) has won a prestigous UBC Killam Research Prize. Killam prizes are awarded to full-time faculty members in recognition of outstanding research and scholarly contributions in all fields of research. Dr. Levings is a world leader in the study of an important immune cells called T regulatory cells (Tregs). Tregs are central to immune tolerance and are a very promising new therapeutic tool. Dr Levings aims to exploit the natural capacity of Tregs to induce immune tolerance and to design effective therapies to restore immune tolerance in patients with immune-mediated disease.